Teleflex - TFX Stock Forecast, Price & News

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Analyst Upgrades and Downgrades

Several research firms have recently commented on TFX. Morgan Stanley reduced their price target on Teleflex from $300.00 to $278.00 and set an "equal weight" rating for the company in a research report on Friday, July 29th. StockNews.com downgraded Teleflex from a "buy" rating to a "hold" rating in a research note on Friday, July 29th. TheStreet downgraded Teleflex from a "b-" rating to a "c+" rating in a research note on Monday, May 16th. Royal Bank of Canada dropped their target price on Teleflex from $390.00 to $380.00 in a research note on Monday, May 23rd. Finally, Wolfe Research began coverage on Teleflex in a research note on Tuesday, July 5th. They set an "outperform" rating and a $300.00 target price on the stock. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, Teleflex currently has a consensus rating of "Moderate Buy" and an average target price of $340.09.

Teleflex Stock Performance

Shares of TFX traded up $3.42 during mid-day trading on Friday, reaching $256.95. The company had a trading volume of 133,123 shares, compared to its average volume of 558,410. Teleflex has a 52-week low of $235.01 and a 52-week high of $405.89. The company has a quick ratio of 1.43, a current ratio of 2.27 and a debt-to-equity ratio of 0.42. The stock has a market capitalization of $12.05 billion, a P/E ratio of 23.88, a PEG ratio of 2.49 and a beta of 1.10. The stock has a 50 day moving average of $255.56 and a two-hundred day moving average of $296.44.

Teleflex (NYSE:TFX - Get Rating) last posted its quarterly earnings results on Thursday, July 28th. The medical technology company reported $3.39 EPS for the quarter, beating the consensus estimate of $3.34 by $0.05. The firm had revenue of $704.50 million during the quarter, compared to analysts' expectations of $719.50 million. Teleflex had a return on equity of 16.84% and a net margin of 18.16%. The business's revenue for the quarter was down 1.3% on a year-over-year basis. During the same quarter last year, the firm earned $3.35 earnings per share. On average, analysts expect that Teleflex will post 13.18 earnings per share for the current year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 15th. Shareholders of record on Monday, August 15th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.53%. The ex-dividend date of this dividend is Friday, August 12th. Teleflex's dividend payout ratio (DPR) is 12.64%.

Insider Transactions at Teleflex

In other news, Director Stuart A. Randle sold 3,014 shares of the business's stock in a transaction that occurred on Tuesday, June 7th. The stock was sold at an average price of $283.31, for a total transaction of $853,896.34. Following the sale, the director now owns 4,320 shares of the company's stock, valued at approximately $1,223,899.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.28% of the company's stock.